These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8103095)

  • 1. Chemical and physicochemical characterization of petrolatums used in eye ointment formulations.
    De Muynck C; Lalljie SP; Sandra P; De Rudder D; Van Aerde P; Remon JP
    J Pharm Pharmacol; 1993 Jun; 45(6):500-3. PubMed ID: 8103095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of physical properties and drug-releasing characteristics of white petrolatums.
    Ogita Y; Takahashi Y; Iwata M; Sasatsu M; Onishi H; Hashimoto S; Machida Y
    Pharmazie; 2010 Nov; 65(11):801-4. PubMed ID: 21155385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Manufacturing Process Variables on the Properties of Ophthalmic Ointments of Tobramycin.
    Patere S; Newman B; Wang Y; Choi S; Vora S; Ma AWK; Jay M; Lu X
    Pharm Res; 2018 Jul; 35(9):179. PubMed ID: 30046909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical attributes of white petrolatum from various sources used for ophthalmic ointment formulations.
    Bao Q; Morales-Acosta MD; Burgess DJ
    Int J Pharm; 2020 Jun; 583():119381. PubMed ID: 32360506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microemulsions with timolol as potential eye drops.
    Malina I; Radomska-Soukharev A
    Pharmazie; 2006 Jul; 61(7):650-1. PubMed ID: 16889077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A method for the obtaining of increased viscosity eye drops containing amikacin.
    Sikora A; Oszczapowicz I; Tejchman B; Grzechnik M
    Acta Pol Pharm; 2005; 62(1):31-7. PubMed ID: 16022491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation of Carbopol 940 ophthalmic vehicles, and in vitro evaluation of the influence of simulated lacrimal fluid on their physico-chemical properties.
    Unlü N; Ludwig A; van Ooteghem M; Hincal AA
    Pharmazie; 1991 Nov; 46(11):784-8. PubMed ID: 1811229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the force effect of aqueous and oily eye drops.
    Müller F; Wagner M; Neubert RH
    Pharmazie; 2005 Apr; 60(4):283-7. PubMed ID: 15881609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [THE THIXOTROPIC NATURE OF PETROLATUMS].
    VANOOTEGHEM M
    Pharm Acta Helv; 1964 Nov; 39():679-86. PubMed ID: 14336865
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of mixing procedure itself on the structure, viscosity, and spreadability of white petrolatum and salicylic acid ointment and the skin permeation of salicylic acid.
    Kitagawa S; Fujiwara M; Okinaka Y; Yutani R; Teraoka R
    Chem Pharm Bull (Tokyo); 2015; 63(1):43-8. PubMed ID: 25400272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applications of poloxamers in ophthalmic pharmaceutical formulations: an overview.
    Almeida H; Amaral MH; Lobão P; Sousa Lobo JM
    Expert Opin Drug Deliv; 2013 Sep; 10(9):1223-37. PubMed ID: 23688342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheological characterization of petrolatum using a controlled stress rheometer.
    Pandey P; Ewing GD
    Drug Dev Ind Pharm; 2008 Feb; 34(2):157-63. PubMed ID: 18302034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Manufacturing Conditions on Pharmaceutical Properties of Petrolatum Ointment-Distribution of Hydrocarbon.
    Ashizuka Y; Otoguro S; Horisawa E
    Chem Pharm Bull (Tokyo); 2021; 69(4):352-359. PubMed ID: 33790080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bulgarian research works on ointment bases and ointments. Review].
    Draganova L; Christov K
    Pharmazie; 1970 Sep; 25(9):514-6. PubMed ID: 4926497
    [No Abstract]   [Full Text] [Related]  

  • 15. [Activation energies in plastic deformation of ointment gels].
    Hüttenrauch R
    Pharmazie; 1973 Apr; 28(4):244-9. PubMed ID: 4716609
    [No Abstract]   [Full Text] [Related]  

  • 16. Viscosity of pharmacopeial multimolecular ointment vehicles and pharmaceutical availability of a model therapeutic agent.
    Piechota-Urbańska M; Kołodziejska J; Zgoda MM
    Polim Med; 2007; 37(2):3-19. PubMed ID: 17957945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of Manufacturing Conditions on Pharmaceutical Properties of Petrolatum Ointment].
    Ashizuka Y; Horisawa E
    Yakugaku Zasshi; 2016 Aug; 136(8):1161-9. PubMed ID: 27193304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives on Physicochemical and In Vitro Profiling of Ophthalmic Ointments.
    Bao Q; Burgess DJ
    Pharm Res; 2018 Oct; 35(12):234. PubMed ID: 30324424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of an ophthalmic micellar formulation of cyclosporine A in unopened multidose eyedroppers and in simulated use conditions.
    Chennell P; Delaborde L; Wasiak M; Jouannet M; Feschet-Chassot E; Chiambaretta F; Sautou V
    Eur J Pharm Sci; 2017 Mar; 100():230-237. PubMed ID: 28131754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative pharmaceutical evaluation of brand and generic clobetasone butyrate ointments.
    Yamamoto Y; Fukami T; Koide T; Onuki Y; Suzuki T; Metori K; Katori N; Hiyama Y; Tomono K
    Int J Pharm; 2014 Mar; 463(1):62-7. PubMed ID: 24406671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.